Fig 2 - by Raheleh Farahzadi (3860311)

Plasma protein levels and thrombin binding sites distribution of the subsets of top and bottom 2% of fibrin concentration of 10,000 simulations. by Jason Chen (15937)

Characteristics of patients in the Optum dataset listed as having been prescribed VPA in the retrospective cohort of patients tested for COVID-19. by Amanda Watson (4447267)

Relative importance (%IncMSE) of explanatory factors in oxidation and antioxidant indexes responses to elevated O₃. by Yi Zhao (14034)

Characteristics of patients prescribed or not prescribed VPA in the retrospectivecohort of COVID-19 infected patients. by Amanda Watson (4447267)

Sociodemographic characteristics and clinical history of participants. by Raphäel Rakotozandrindrainy (18389756)

Fig 7 - by Amanda Watson (4447267)

Experimental setup of the chemotaxis assay. by Yixuan Chen (47490)

Data for meta-analysis in this study. by Yi Zhao (14034)

“…When the exposure time was more than 60 days, SOD activity did not increase but significantly decreased by 12.1%. However, the POD activity of herbaceous plants increased by 30.4%, 57.3%, 21.9% and 5.81%, respectively, when exposure time of herbaceous plants in elevated O₃ environment was 1–12, 13–30, 31–60 and more than 60 days. …”

Data dictionary used to include the variables in the analysis. by Raphäel Rakotozandrindrainy (18389756)

Estimates of the prevalence of schistosome infection with respective 95% confidence intervals. by Raphäel Rakotozandrindrainy (18389756)

Flowchart of participants’ recruitment and urine sampling. by Raphäel Rakotozandrindrainy (18389756)

Diet composition and nutritional values. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Nutritional and metabolic analysis. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Cardiovascular parameters. by Taynara Aparecida Vieira (16401726)

“…The HSF group exhibited obesity (HSF 8.77 ± 2.64 <i><i>vs</i></i> C 3.09 ± 1.02, <i>p = </i>0.007), dyslipidemia (HSF 94.4 ± 19.1 <i><i>vs</i></i> C 26.7 ± 5.2, <i><i>p < </i></i>0.001), hypertension (HSF 141 ± 8 <i><i>vs</i></i> C 120 ± 4, <i>p = </i>0.001), insulin resistance (HSF 6.91 ± 1.38 <i><i>vs</i></i> C 2.47 ± 1.01, <i><i>p < </i></i>0.001), cardiac remodeling and dysfunction, cardiac inflammation, decreased metalloproteinase-2 (MMP-2) (HSF 0.43 ± 0.09 <i><i>vs</i></i> C 0.71 ± 0.07, <i>p = </i>0.009) and increased type III collagen (HSF 1.32 ± 0.27 <i><i>vs</i></i> C 1.00 ± 0.18, <i>p = </i>0.038). …”

Viral inhibition assays around the IC50 of VPA by direct inhibition of HDAC2. by Amanda Watson (4447267)

Meta-analysis of the effects of elevated O₃ on POD activity of herbaceous plants. by Yi Zhao (14034)

Theory of change enhanced by integrating schistosomiasis treatment for pregnant women into public health programs. by Raphäel Rakotozandrindrainy (18389756)

Ultra-performance liquid chromatography–electrospray ionization–mass spectrometry analysis of Moutan Cortex extract. by Jin-Hwa Kim (101817)

In vitro multilineage differentiation of hADSCs. by Raheleh Farahzadi (3860311)